Investor Ideas #Potcasts
628, #Cannabis News and #Stocks on the Move (OTC: $TPIA), (TSXV: $MUSH.V),
(CSE: $TRUL.C) (OTCQX: $TCNNF)
Delta, Kelowna, BC, March 18, 2022 (Investorideas.com Newswire),
investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/031822-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2022/cannabis-potcasts/03181TPIA-MUSH-TRUL-TCNNF.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast
we look at a few private and public company announcements.
Now
everyone can contribute to world-changing scientific
discoveries with the right tools and questions. Quantified Citizen is a mobile health research platform that powers
scientific discovery through digitized health measures and a community of
professional researchers and citizen scientists.
The
app leverages standard health measures that make it easy for anyone to rapidly
create and deploy behavioral research studies. It has a growing library of
studies on interventions like psychedelic microdosing for mental health,
conditions like sobriety and its connections to mood, creativity, productivity
and more. Anyone can choose studies based on their interests and, in as little
as two minutes a day, contribute to global health and science.
"We
envision a world where doing scientifically valid health research is as fast
and easy as creating a website, with the same global reach. Where scientific
tinkering and self-examination are normalized, vastly accelerating the pace of
discovery by unlocking unexamined data," shares co-founder and CEO Eesmyal
Santos-Brault.
Quantified
Citizen's study on psychedelic microdosing's effects on cognitive performance
and mental health was recently published in the prestigious Nature Scientific
Reports. The study, informally called Microdose.me, is the largest microdosing
study in the world at 17,000 participants and counting, and has been presented
at numerous conferences, including Exponential Medicine, SXSW, Summit LA, and
soon TED and Life Itself.
"For way too
long, science has been the domain of a professional class, and citizens have
been merely passive observers. By partnering with citizen scientists, we aim to
empower a generation of amateur researchers, and unlock scientific curiosity,
imagination, and creativity on a scale never seen before," says co-founder
and CTO Kalin Harvey
The
Quantified Citizen app is available on iOS and Android. A recent update offers
visual redesign, new tasks and activities, and the ability to connect Apple
Health or Google Fit.
New
studies have also been announced:
●
Impact of COVID-19 -
Exploring the impact of the COVID-19 pandemic on various aspects of mental
health and social relationships.
●
Mental Health Tracker -
Does mental health fluctuate with the seasons? Is it affected by a new routine
or treatment regimen like a new medication?
●
Attitudes Towards
Psychedelics - A global survey of attitudes and beliefs towards psychedelics.
●
Sobriety and Well-being
Study - How abstaining from alcohol or cannabis for one month affects sleep.
●
Personality and Drug Use -
Do drugs play a role in altering our personalities?
To
fuel further growth and development of new study capabilities, Quantified
Citizen is pleased to announce the closing of its oversubscribed Series Seed
financing round, led by Bicycle Day Ventures and Limitless, along with notable
investors Paul Stamets, Lance Tracey, Iter Investments, and Empath Ventures.
Mycotopia Therapies
Inc.
(OTC: TPIA), a biopharma company focused on
research, technology, and the development of medical psychedelics, announced plans to expand its supply agreement
with Havn Life Sciences (CSE: HAVN) (OTC: HAVLF) to include functional mushrooms,
which refers specifically to varieties of mushrooms that have a health benefit
beyond providing nutrition. The terms of the original agreement call for Havn
Life Sciences to supply Mycotopia Therapies with naturally-derived psilocybin.
Under the terms of the agreement, Mycotopia Therapies is classified as a
specialty pharmaceutical company focused on the research, development, and
commercialization of novel therapeutics for unmet needs.
Under
the terms of the existing agreement, Mycotopia Therapies is building a
distribution channel to supply naturally-derived psilocybin compounds, in
accordance with all federal laws and local protocols, to universities,
researchers and companies. The expanded agreement Mycotopia Therapies provides
Mycotopia Therapies with the opportunity to distribute functional mushrooms, as
well as the white label supply and distribution of HAVN’s line of natural OTC
health products currently being registered with the Jamaican Ministry of Health
(MOH). Jamaica’s Ministry of Health is the pre-eminent Government organization
whose mandate is “To ensure the provision of quality health services and to
promote healthy lifestyles and environmental practices.” The Ministry, together
with its Regional Health Authorities, Agencies and related organizations make
up the public health system and are responsible for health care delivery across
the island.
In
December 2021 Mycotopia Therapies Inc. announced it had entered into a letter
of intent regarding a potential acquisition of botanical psilocybin pioneer,
Ei.Ventures. When a definitive agreement is reached, the combined companies
intend to pool their resources to develop regulatory approved, plant-derived,
psychoactive therapeutic treatment options and non-psychoactive nutritional
supplements and related products that address global mental healthcare needs.
Upon closing, the company would be renamed PSLY.com to better reflect the
Company’s business moving forward.
Mycotopia
Therapies is focused on the research, development, and commercialization of
novel therapeutics based on naturally-derived psilocybin. Performing most of
its research in Jamaica, where psilocybin is legal, Mycotopia Therapies is
focused on mushroom and psychedelic opportunities. Ei.Ventures’ flagship
botanical psilocybin-based formulation Psilly is a whole-plant botanical
psilocybin-based formulation, which is currently in the pre-clinical phase. The
goal of the combined companies would be to complete pre-clinical and phase 1
trials and launch therapeutic Psilly into jurisdictions where psilocybin is legal.
Ei.Ventures has pioneered using the whole plant and fungi in its botanical
formulations, which has the potential to create the “Entourage Effect.”
Researchers suggest the Entourage Effect could be key to Psilocybin’s healing
properties. The Entourage Effect is a synergistic interaction between two or
more different molecules found within the same plant, which is similar to the
effects various strains of cannabis has on the end-user.
Ben
Kaplan, CEO of Mycotopia Therapies said, "Mushrooms were the second
highest growing natural health supplement and are underserviced in the market.
This partnership helps support our company's ambitious product development and
R&D milestones by offering a potential alternative to synthetic derived
psilocybin at a fraction of the cost.” Mr. Kaplan continued, “Since Havn Life
Sciences will supply Mycotopia Therapies with functional mushroom, it helps
addresses potential supply chain issues and enables Mycotopia Therapies to get
to the distribution and revenue generation phase of our business plan, as we
join forces with eI.ventures and form PSLY.com."
The Good Shroom Co
Inc.
(TSXV: MUSH), provides an update on sales and
distribution.
MUSH,
through its licensed subsidiary Teonan Biomedical Inc. (the
"Subsidiary"), operates 2 cannabis brands; Nordique Royale™ and
Velada™representing functional cannabis beverages and popular hash extracts.
December 24, 2021 marked the launch of Nordique Royale's Afghan Gold hashish in
Quebec. According to https://quebec.weedcrawler.ca/best_sellers,
three weeks later the product was ranked #4 in sales in its category out of
approximately 35 hash products. During
that same period hash sales for the Company were just over $250K and are
expected to continue for the immediate term.
The
first week of February 2022 marked the launch of the first two Velada™ cannabis
beverages in Ontario. According to the Ontario Cannabis Store, for its first
week of sales Velada™ products ranked #1 and #2 in its category, representing
$27,480 in sales.
For
both Nordique Royale™ and Velada™ sales quickly surpassed expectations and
inventory was depleted much quicker than anticipated which led to a temporary
drop in sales. At present, all cannabis
products have been restocked or are in process of being completed in line with
revised projections to ensure MUSH minimizes any disruptions in inventory going
forward.
MUSH
also expects to launch 2 Velada cannabis beverages in every single Quebec
cannabis store the week of February 21, 2022. At present in Quebec Velada
cannabis beverages are only sold online. According to the government of Quebec
online sales account for approximately 10% of total sales in the province.
Despite only being sold online, according to quebec.weed
crawler.ca, 3 Velada beverages are in the top selling products in
its category even when ranked against products sold in stores.
MUSH,
through the Subsidiary, also operates Teonan™ functional mushroom
beverages. These beverages have been
accepted by two of the largest consumer packaged goods distributors in the
United States, KEHE Food Distributors Inc. ("Kehe") and United
Natural Foods Inc. ("UNFI").
As a result, Teonan™ is now distributed out of several locations and
available to all retailers in the US. Though just initiated recently, the
Subsidiary has already received 4 purchase orders which include two large
accounts and a variety of small accounts. MUSH sales force led by FDM Sales
management has now begun fulfilling orders and submitting products for review
with its large retail accounts.
GreenBroz
Inc.,
known as an industry-disruptive innovator of post-harvest processing technology
for the cannabis industry, today officially announced the release of their Model G Precision Grinder + Destemmer.
Featuring a first-of-its-kind continuous throughput system, the Model G is the
first combination destemmer and grinder on the market.
Removing stems from milled flower
efficiently while maintaining product quality and controlling particle size
have been substantial obstacles for operators to overcome.
"It is a significant milestone
for us to be able to deliver this technology that solves the long-standing
problem of creating uniform particulates for the pre-roll, concentrates and
edibles segments while maintaining a high degree of quality, efficiency and
throughput," said Cullen Raichart, Founder and CEO of GreenBroz Inc.
"Five years of concentrated work by our engineering team and countless
hours of testing has produced what we are confident is an enduring
solution."
The R&D team's key innovation is
the Model G's patent-pending triangular blade assembly. When combined with the
low torque, low-RPM motor it allows for a high degree of control over particle
size while its gentle actuation generates less heat, maintaining the integrity
of high-value terpenes and trichomes, maximizing THC content per pound.
"Unlike other machines on the
market today that pulverize buds, the Model G was designed to gently
deconstruct the bud to yield the uniform grind size of your choice," said
GreenBroz Engineer Dylan Cruz. The Model G comes with 1/8-inch, 5/32-inch or
3/16-inch mill size interchangeable screens, giving customers control and
flexibility. The unit can be completely customized by adding a stainless steel
perforated metal sheet of any size.
Engineered to be gentle and
efficient, the Model G is made in the U.S. at the GreenBroz Las Vegas
manufacturing facility and can process over 100 pounds per hour.
Trulieve Cannabis
Corp.
(CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing
cannabis company in the United States, launched its nationwide Supplier Diversity
Initiative. The initiative provides education and professional development
resources, while creating mutually beneficial business relationships with a
supplier base reflective of the customers and communities Trulieve serves.
Suppliers
nationwide are encouraged to register with Trulieve's supplier database.
Through the Company's comprehensive Supplier Diversity Initiative, Trulieve
will consider all varieties of products and services from marketing and
software, to cleaning supplies, training, construction and other ancillary
services that support Trulieve's day-to-day operations.
"Trulieve's
Supplier Diversity Initiative showcases how cannabis leaders can positively
impact local business communities while promoting diversity, equity, and inclusion
throughout the cannabis industry," said Kim Rivers,
CEO of Trulieve. "As Trulieve broadens its services and operations, we
look forward to establishing new professional relationships with diverse
business owners who wish to be active participants in this rapidly growing
sector."
As
corporate members of the National Minority Supplier Development Council,
Women's Business Enterprise National Council, Small Business Administration,
Veterans in Business Network, National Gay & Lesbian Chamber of Commerce,
and Disability Inclusion, Trulieve is actively seeking partnerships with diverse
suppliers by participating with these certifying organizations and attending
council events.
In
November 2021, Trulieve published its inaugural Environment, Social, and
Governance (ESG) Report establishing several long-term Diversity, Equity, and
Inclusion (DEI) initiatives. The Supplier Diversity Initiative is the latest
extension of Trulieve's commitment to creating a more inclusive and accessible
cannabis industry aligned with the Company's ethics and governance standards.
Since entering Georgia, Trulieve has already allocated a significant portion of
its supplier contracts to local minority, woman and veteran-owned companies –
well above the state's recommended 20% diversity threshold.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
To
hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and the AI
Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
